MwanzoNOVN • SWX
Novartis AG
CHF 93.68
22 Nov, 22:05:00 GMT +1 · CHF · SWX · Kanusho
HisaNembo ya GLeafInaongoza katika utunzaji wa mazingiraHisa zinazouzwa CHMakao yake makuu ni CH
Bei iliyotangulia
CHF 91.56
Bei za siku
CHF 92.04 - CHF 93.99
Bei za mwaka
CHF 83.63 - CHF 102.72
Thamani ya kampuni katika soko
205.76B CHF
Wastani wa hisa zilizouzwa
2.97M
Uwiano wa bei na mapato
12.39
Mgao wa faida
3.52%
Ubadilishanaji wa msingi
SWX
Alama ya CDP ya Tabia Nchi
A
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
13.17B8.93%
Matumizi ya uendeshaji wa biashara
5.52B-24.45%
Mapato halisi
3.19B81.09%
Kiwango cha faida halisi
24.2166.28%
Mapato kwa kila hisa
2.0618.39%
EBITDA
5.50B88.62%
Asilimia ya kodi ya mapato
5.91%
Jumla ya mali
Jumla ya dhima
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
13.85B8.08%
Jumla ya mali
103.52B-8.14%
Jumla ya dhima
60.08B-19.30%
Jumla ya hisa
43.44B
hisa zilizosalia
2.00B
Uwiano wa bei na thamani
4.23
Faida inayotokana na mali
10.97%
Faida inayotokana mtaji
15.05%
Mabadiliko halisi ya pesa taslimu
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
3.19B81.09%
Pesa kutokana na shughuli
6.29B16.88%
Pesa kutokana na uwekezaji
-374.00M83.09%
Pesa kutokana na ufadhili
-382.00M54.09%
Mabadiliko halisi ya pesa taslimu
5.71B275.39%
Mtiririko huru wa pesa
4.55B-63.57%
Kuhusu
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes”. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
29 Feb 1996
Wafanyakazi
76,057
Gundua zaidi
Huenda unavutiwa na
Orodha hii imetokana na maudhui uliyotafuta hivi majuzi, hisa unazofuatilia na shughuli zingine. Pata maelezo zaidi

Data na maelezo yote hutolewa “kama yalivyo” kwa madhumuni ya taarifa binafsi tu, wala hayanuii kuwa ushauri wa kifedha na hayana madhumuni ya kufanya biashara au uwekezaji, kodi, kisheria, uhasibu au ushauri mwingine. Google si mshauri wa uwekezaji wala mshauri wa kifedha na haitoi maoni au mapendekezo yanayohusiana na kampuni zozote zilizojumuishwa kwenye orodha hii au hisa zozote zilizotolewa na kampuni hizo. Tafadhali wasiliana na dalali wako au mwakilishi wa kifedha ili uthibitishe bei kabla ya kufanya biashara yoyote. Pata maelezo zaidi
Watu pia hutafuta
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu